Bakheet Kholoud, Habiballah Saddiq, Basahl Emtenan, Algiraigri Ali, Alsaidalani Ashwag, Nashawi Mohammed
Pediatrics, King Abdulaziz University Faculty of Medicine, Jeddah, SAU.
Pediatric Rheumatology, King Abdulaziz University Hospital, Jeddah, SAU.
Cureus. 2023 Nov 21;15(11):e49168. doi: 10.7759/cureus.49168. eCollection 2023 Nov.
Immune thrombocytopenic purpura is one of the most common causes of low platelet count in the pediatric population. Secondary thrombocytopenia has a wide differential diagnosis in children, including rheumatological, hematological, and immunological etiologies. Underlying etiologies must be excluded if suspected before labeling the patient as primary thrombocytopenia. Here, we report two siblings with persistent and profound thrombocytopenia. A 10-year-old girl presented with profound and treatment-refractory thrombocytopenia. Given the patient's family history of thrombocytopenia of unknown pathology in her older brother, immune dysregulation-related thrombocytopenia was suspected. Whole exome sequencing confirmed a previously reported pathogenic variant in the gene linked to common variable immunodeficiency 12 (CVID-12) diagnosis for both patients.
免疫性血小板减少性紫癜是儿科人群血小板计数低的最常见原因之一。继发性血小板减少症在儿童中有广泛的鉴别诊断,包括风湿性、血液学和免疫学病因。如果怀疑有潜在病因,在将患者标记为原发性血小板减少症之前必须排除。在此,我们报告了两名患有持续性和严重血小板减少症的兄弟姐妹。一名10岁女孩出现严重且对治疗难治的血小板减少症。鉴于该患者的哥哥有病因不明的血小板减少症家族史,怀疑是免疫失调相关的血小板减少症。全外显子组测序证实,两名患者均存在先前报道的与常见变异型免疫缺陷12(CVID - 12)诊断相关基因的致病变异。